Table 1. Clinical characteristics of 181 patients with COVID-19 caused by SARS-CoV-2, according to disease severity.

Clinical characteristics Mean (range)	Tocilizumab treatment (n=92)	Conventional treatment (n=89)	P
Age, mean (range), years	68.8 (25-87)	66.8 (25-85)	0.258
Gender			0.213
Male	57/92(62.0%)	47/89 (52.8%)
Female	35/92(38.0%)	42/89 (47.2%)
Coexisting disorders	65/92(70.7%)	25/89 (28.1%)	0.001
State of illness			0.001
Critical or severe	78/92 (84.8%)	41/89 (46.1%)
Moderate	14/92 (15.2%)	48/89 (53.9%)
Hospitalization days (range) – days	27.5 (6-62)	16.4 (4-46)	0.001
Clinical outcome			0.018
Discharge from hospital	83/92 (90.2%)	88/89 (98.9%)
Dead	9/92 (9.8%)	1/89 (1.1%)
Negative-conversing, mean (range), days	22.4 (1-57)	18.8 (1-57)	0.184